Skip to main content
Premium Trial:

Request an Annual Quote

Igenbio, Genome Compiler Team to Create Synthetic Bio Solutions

NEW YORK (GenomeWeb) – Genome analysis firm Igenbio said today it has struck a collaborative agreement with the synthetic biology software design firm Genome Compiler to develop new solutions targeting the synthetic biology community.

The partners will use Chicago-based Igenbio's ERGO genome and analysis discovery system and Genome Compiler's proprietary biology designs solution. ERGO is a web-based platform that integrates functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with other information in the public sphere.

Genome Compiler, based in Los Angeles, provides a software platform for bio-engineering and genomic manipulation tools.

"Partnering with Genome Compiler to create a single integrated platform providing exceptional annotations, pathways, and an enormous curated parts database across all genomes will enable scientists to expedite new product creation," Igenbio's President and CEO Vinayak Kapatral said in a statement.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.